nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2A6—Metabolism—MARCKS—salivary gland cancer	0.00143	0.00143	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL17RD—salivary gland cancer	0.00141	0.00141	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PHGDH—salivary gland cancer	0.0014	0.0014	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ISYNA1—salivary gland cancer	0.00138	0.00138	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MC3R—salivary gland cancer	0.00136	0.00136	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—DTX4—salivary gland cancer	0.00135	0.00135	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ST3GAL4—salivary gland cancer	0.00135	0.00135	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PYGB—salivary gland cancer	0.00133	0.00133	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MAP2K2—salivary gland cancer	0.00131	0.00131	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00131	0.00131	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MAML3—salivary gland cancer	0.00129	0.00129	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—NUP62—salivary gland cancer	0.00123	0.00123	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—AQP1—salivary gland cancer	0.00123	0.00123	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—VCAN—salivary gland cancer	0.00122	0.00122	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.0012	0.0012	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ISYNA1—salivary gland cancer	0.0012	0.0012	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PHGDH—salivary gland cancer	0.00119	0.00119	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—DTX4—salivary gland cancer	0.00119	0.00119	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PHGDH—salivary gland cancer	0.00118	0.00118	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MC3R—salivary gland cancer	0.00115	0.00115	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ST3GAL4—salivary gland cancer	0.00115	0.00115	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ST3GAL4—salivary gland cancer	0.00114	0.00114	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MARCKS—salivary gland cancer	0.00113	0.00113	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—FGF16—salivary gland cancer	0.00112	0.00112	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.0011	0.0011	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PHGDH—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NOTCH1—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00107	0.00107	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ISYNA1—salivary gland cancer	0.00107	0.00107	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PYGB—salivary gland cancer	0.00105	0.00105	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ST3GAL4—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—AQP1—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—AQP1—salivary gland cancer	0.00103	0.00103	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—DTX4—salivary gland cancer	0.001	0.001	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	0.000982	0.000982	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—FGF16—salivary gland cancer	0.000981	0.000981	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MARCKS—salivary gland cancer	0.000975	0.000975	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CREBBP—salivary gland cancer	0.000975	0.000975	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ISYNA1—salivary gland cancer	0.000973	0.000973	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—NUP62—salivary gland cancer	0.000972	0.000972	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MAML2—salivary gland cancer	0.000972	0.000972	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—VCAN—salivary gland cancer	0.000965	0.000965	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000953	0.000953	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000948	0.000948	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—AQP1—salivary gland cancer	0.000945	0.000945	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00093	0.00093	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000915	0.000915	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PYGB—salivary gland cancer	0.000906	0.000906	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MARCKS—salivary gland cancer	0.00087	0.00087	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PHGDH—salivary gland cancer	0.000853	0.000853	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MAML2—salivary gland cancer	0.000852	0.000852	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000849	0.000849	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000847	0.000847	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ISYNA1—salivary gland cancer	0.000832	0.000832	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000831	0.000831	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000831	0.000831	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—JAG1—salivary gland cancer	0.00083	0.00083	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FGF16—salivary gland cancer	0.000829	0.000829	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—FGFR4—salivary gland cancer	0.000827	0.000827	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NUP62—salivary gland cancer	0.000825	0.000825	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ST3GAL4—salivary gland cancer	0.000821	0.000821	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—VCAN—salivary gland cancer	0.000819	0.000819	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NUP62—salivary gland cancer	0.000818	0.000818	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—FBXW7—salivary gland cancer	0.000813	0.000813	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—VCAN—salivary gland cancer	0.000811	0.000811	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PYGB—salivary gland cancer	0.000809	0.000809	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MARCKS—salivary gland cancer	0.0008	0.0008	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MARCKS—salivary gland cancer	0.000793	0.000793	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PYGB—salivary gland cancer	0.00079	0.00079	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—HRAS—salivary gland cancer	0.000769	0.000769	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NUP62—salivary gland cancer	0.00075	0.00075	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—AQP1—salivary gland cancer	0.000746	0.000746	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PYGB—salivary gland cancer	0.000744	0.000744	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—VCAN—salivary gland cancer	0.000744	0.000744	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PHGDH—salivary gland cancer	0.000739	0.000739	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PYGB—salivary gland cancer	0.000738	0.000738	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—JAG1—salivary gland cancer	0.000728	0.000728	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—FGFR4—salivary gland cancer	0.000725	0.000725	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CCND1—salivary gland cancer	0.000721	0.000721	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MAML2—salivary gland cancer	0.00072	0.00072	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—FBXW7—salivary gland cancer	0.000713	0.000713	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ST3GAL4—salivary gland cancer	0.000711	0.000711	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000703	0.000703	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—PTEN—salivary gland cancer	0.000696	0.000696	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000688	0.000688	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—FOXO3—salivary gland cancer	0.000686	0.000686	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000683	0.000683	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MARCKS—salivary gland cancer	0.000678	0.000678	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000664	0.000664	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—EP300—salivary gland cancer	0.000664	0.000664	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PHGDH—salivary gland cancer	0.000659	0.000659	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—AQP1—salivary gland cancer	0.000646	0.000646	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000644	0.000644	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000642	0.000642	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ST3GAL4—salivary gland cancer	0.000635	0.000635	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000634	0.000634	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PYGB—salivary gland cancer	0.00063	0.00063	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.00062	0.00062	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—JAG1—salivary gland cancer	0.000615	0.000615	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FGFR4—salivary gland cancer	0.000613	0.000613	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PHGDH—salivary gland cancer	0.000607	0.000607	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000605	0.000605	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FBXW7—salivary gland cancer	0.000603	0.000603	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—FOXO3—salivary gland cancer	0.000602	0.000602	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PHGDH—salivary gland cancer	0.000601	0.000601	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NUP62—salivary gland cancer	0.000591	0.000591	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—VCAN—salivary gland cancer	0.000587	0.000587	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	0.000584	0.000584	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ST3GAL4—salivary gland cancer	0.000579	0.000579	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000577	0.000577	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—AQP1—salivary gland cancer	0.000576	0.000576	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000563	0.000563	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MAP2K2—salivary gland cancer	0.00056	0.00056	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—AQP1—salivary gland cancer	0.00053	0.00053	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—AQP1—salivary gland cancer	0.000526	0.000526	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000523	0.000523	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PHGDH—salivary gland cancer	0.000514	0.000514	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NUP62—salivary gland cancer	0.000512	0.000512	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—FOXO3—salivary gland cancer	0.000508	0.000508	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—VCAN—salivary gland cancer	0.000508	0.000508	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ST3GAL4—salivary gland cancer	0.000495	0.000495	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000491	0.000491	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—PIK3CA—salivary gland cancer	0.000491	0.000491	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000486	0.000486	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CREBBP—salivary gland cancer	0.000477	0.000477	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TP53—salivary gland cancer	0.000475	0.000475	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000469	0.000469	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000459	0.000459	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NUP62—salivary gland cancer	0.000457	0.000457	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HRAS—salivary gland cancer	0.000454	0.000454	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—VCAN—salivary gland cancer	0.000453	0.000453	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000453	0.000453	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—AQP1—salivary gland cancer	0.000449	0.000449	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000446	0.000446	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000446	0.000446	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000443	0.000443	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000427	0.000427	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NUP62—salivary gland cancer	0.00042	0.00042	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—VCAN—salivary gland cancer	0.000417	0.000417	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NUP62—salivary gland cancer	0.000417	0.000417	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CREBBP—salivary gland cancer	0.000416	0.000416	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000415	0.000415	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—VCAN—salivary gland cancer	0.000413	0.000413	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000402	0.000402	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000398	0.000398	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000397	0.000397	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000391	0.000391	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000382	0.000382	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CREBBP—salivary gland cancer	0.000377	0.000377	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000369	0.000369	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CREBBP—salivary gland cancer	0.000365	0.000365	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000363	0.000363	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NUP62—salivary gland cancer	0.000356	0.000356	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000355	0.000355	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—VCAN—salivary gland cancer	0.000353	0.000353	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000347	0.000347	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000343	0.000343	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTEN—salivary gland cancer	0.000341	0.000341	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOTCH1—salivary gland cancer	0.00034	0.00034	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HRAS—salivary gland cancer	0.000328	0.000328	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—EP300—salivary gland cancer	0.000325	0.000325	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CREBBP—salivary gland cancer	0.00032	0.00032	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000318	0.000318	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CREBBP—salivary gland cancer	0.000317	0.000317	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000311	0.000311	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.00031	0.00031	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CREBBP—salivary gland cancer	0.000308	0.000308	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCND1—salivary gland cancer	0.000308	0.000308	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000304	0.000304	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PTEN—salivary gland cancer	0.000297	0.000297	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CREBBP—salivary gland cancer	0.000291	0.000291	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.00029	0.00029	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HRAS—salivary gland cancer	0.000288	0.000288	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000284	0.000284	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—EP300—salivary gland cancer	0.000283	0.000283	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000275	0.000275	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000273	0.000273	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000271	0.000271	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCND1—salivary gland cancer	0.00027	0.00027	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTEN—salivary gland cancer	0.000269	0.000269	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000263	0.000263	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PTEN—salivary gland cancer	0.000261	0.000261	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000259	0.000259	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—EP300—salivary gland cancer	0.000257	0.000257	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EP300—salivary gland cancer	0.000248	0.000248	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000247	0.000247	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HRAS—salivary gland cancer	0.000243	0.000243	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PIK3CA—salivary gland cancer	0.00024	0.00024	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CREBBP—salivary gland cancer	0.000229	0.000229	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTEN—salivary gland cancer	0.000229	0.000229	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCND1—salivary gland cancer	0.000228	0.000228	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTEN—salivary gland cancer	0.000226	0.000226	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000225	0.000225	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000221	0.000221	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PTEN—salivary gland cancer	0.00022	0.00022	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—EP300—salivary gland cancer	0.000218	0.000218	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—EP300—salivary gland cancer	0.000216	0.000216	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000211	0.000211	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EP300—salivary gland cancer	0.00021	0.00021	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PIK3CA—salivary gland cancer	0.00021	0.00021	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTEN—salivary gland cancer	0.000208	0.000208	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TP53—salivary gland cancer	0.000203	0.000203	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000201	0.000201	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CREBBP—salivary gland cancer	0.000199	0.000199	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—EP300—salivary gland cancer	0.000198	0.000198	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HRAS—salivary gland cancer	0.000194	0.000194	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PIK3CA—salivary gland cancer	0.00019	0.00019	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PIK3CA—salivary gland cancer	0.000184	0.000184	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000183	0.000183	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TP53—salivary gland cancer	0.000178	0.000178	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CREBBP—salivary gland cancer	0.000177	0.000177	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CREBBP—salivary gland cancer	0.000173	0.000173	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HRAS—salivary gland cancer	0.00017	0.00017	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTEN—salivary gland cancer	0.000164	0.000164	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CREBBP—salivary gland cancer	0.000163	0.000163	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CREBBP—salivary gland cancer	0.000162	0.000162	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PIK3CA—salivary gland cancer	0.000161	0.000161	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PIK3CA—salivary gland cancer	0.00016	0.00016	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000156	0.000156	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—EP300—salivary gland cancer	0.000156	0.000156	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PIK3CA—salivary gland cancer	0.000155	0.000155	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TP53—salivary gland cancer	0.00015	0.00015	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PIK3CA—salivary gland cancer	0.000146	0.000146	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HRAS—salivary gland cancer	0.000144	0.000144	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTEN—salivary gland cancer	0.000142	0.000142	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CREBBP—salivary gland cancer	0.000138	0.000138	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—EP300—salivary gland cancer	0.000135	0.000135	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTEN—salivary gland cancer	0.000127	0.000127	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTEN—salivary gland cancer	0.000124	0.000124	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—EP300—salivary gland cancer	0.000121	0.000121	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—EP300—salivary gland cancer	0.000118	0.000118	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTEN—salivary gland cancer	0.000116	0.000116	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PIK3CA—salivary gland cancer	0.000115	0.000115	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTEN—salivary gland cancer	0.000115	0.000115	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—EP300—salivary gland cancer	0.000111	0.000111	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—EP300—salivary gland cancer	0.00011	0.00011	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CREBBP—salivary gland cancer	0.000107	0.000107	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PIK3CA—salivary gland cancer	0.0001	0.0001	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTEN—salivary gland cancer	9.86e-05	9.86e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—EP300—salivary gland cancer	9.41e-05	9.41e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PIK3CA—salivary gland cancer	8.93e-05	8.93e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PIK3CA—salivary gland cancer	8.72e-05	8.72e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	8.21e-05	8.21e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PIK3CA—salivary gland cancer	8.14e-05	8.14e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTEN—salivary gland cancer	7.61e-05	7.61e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—EP300—salivary gland cancer	7.26e-05	7.26e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	6.96e-05	6.96e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	5.37e-05	5.37e-05	CbGpPWpGaD
